{"news_desk": "National", "print_page": "1", "subsection_name": "Politics", "section_name": "U.S.", "byline": {"original": "By ERIC LIPTON", "person": [{"firstname": "Eric", "rank": 1, "lastname": "LIPTON", "organization": "", "role": "reported"}]}, "abstract": "E-cigarette and cigar industries are hiring prominent lobbyists and influential allies in Congress in effort to halt Food and Drug Administration from retroactively perusing their products for public health risks or outright banning them; fight illustrates tobacco how industry still has outsize power in Washington.", "type_of_material": "News", "word_count": "1664", "keywords": [{"rank": "1", "value": "Smoking and Tobacco", "is_major": "Y", "name": "subject"}, {"rank": "2", "value": "E-Cigarettes", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Cigars", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Lobbying and Lobbyists", "is_major": "Y", "name": "subject"}, {"rank": "5", "value": "Law and Legislation", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Regulation and Deregulation of Industry", "is_major": "N", "name": "subject"}, {"rank": "7", "value": "Altria Group Inc", "is_major": "N", "name": "organizations"}, {"rank": "8", "value": "Food and Drug Administration", "is_major": "Y", "name": "organizations"}], "lead_paragraph": "Nearly two decades after the $200 billion settlement to compensate the public for health consequences of smoking, the industry still wields clout in Washington.", "pub_date": "2016-09-03T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "Nearly two decades after the $200 billion settlement to compensate the public for health consequences of smoking, the industry still wields clout in Washington....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/09/03/us/03tobacco1/03tobacco1-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/09/03/us/03tobacco1/03tobacco1-thumbWide.jpg"}, {"height": 361, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "361", "xlarge": "images/2016/09/03/us/03tobacco1/03tobacco1-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/09/03/us/03tobacco1/03tobacco1-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/09/03/us/03tobacco1/03tobacco1-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/09/03/us/03tobacco1/03tobacco1-thumbStandard-v2.jpg"}], "web_url": "http://www.nytimes.com/2016/09/03/us/politics/e-cigarettes-vaping-cigars-fda-altria.html", "slideshow_credits": null, "blog": [], "_id": "57c93fba95d0e021d7984041", "headline": {"main": "A Lobbyist Wrote the Bill. Will the Tobacco Industry Win Its E-Cigarette Fight?", "print_headline": "Tobacco Lobby Tries to Shield  E-Cigarettes"}}